NASDAQ : KTTA

Pasithea Therapeutics Corp. — Earnings Estimates

$0.46 USD

$0.01 (1.14%)

Volume
344.14K
Average Volume
805.22K
Market Capitalization
$3.42M
P/E Ratio
-0.19
Dividend Yield
0.00%
Price Target
$3.00
Year High
$2.06
Year Low
$0.28
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$35.40

Annual earnings financials

KTTA financial data with annual/quarterly toggle

KTTA GAAP EPS - Annual & Quarterly

KTTA Sales Revenue - Annual & Quarterly

KTTA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

KTTA Estimated and Actual Revenue by Quarter
KTTA Estimated and Actual EPS by Quarter
KTTA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 1 180K 180K 180K 180K 180K 180K
2026-12-31 1 120K 120K 120K 120K 120K 120K
KTTA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-03-31 0 -26.72M -26.72M -26.72M - - -
2027-12-31 0 -25.31M -25.31M -25.31M - - -
2027-09-30 0 -23.91M -23.91M -23.91M - - -
2027-06-30 0 -23.91M -23.91M -23.91M - - -
2027-03-31 1 -23.91M -23.91M -23.91M 18.19M 18.19M 18.19M
2026-12-31 1 -1.69M -1.69M -1.69M 12.12M 12.12M 12.12M
KTTA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-03-31 0 - - - 1 -3.8 -3.8 -3.8
2027-12-31 0 - - - 1 -3.6 -3.6 -3.6
2027-09-30 0 - - - 1 -3.4 -3.4 -3.4
2027-06-30 0 - - - 1 -3.4 -3.4 -3.4
2027-03-31 1 300K 300K 300K 1 -3.4 -3.4 -3.4
2026-12-31 1 200K 200K 200K 1 -0.24 -0.24 -0.24